Aspira Pathlab & Diagnostics Ltd. - Research Center
540788 ASPIRA Group (X) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Profit before tax | -0.09 | 4.46 | 1.38 | -4.24 | -5.17 |
| Net cashflow-operating activity | -0.01 | 2.03 | 5.67 | -1.87 | -3.39 |
| Net cash used in investing activity | 0.16 | -0.51 | -0.09 | 0.24 | -1.97 |
| Netcash used in fin. activity | -0.94 | -1.35 | -2.17 | 1.27 | 3.35 |
| Net inc/dec in cash and equivlnt | -0.79 | 0.17 | 3.41 | -0.35 | -2.00 |
| Cash and equivalnt begin of year | 1.35 | 1.19 | -2.22 | -1.87 | 0.14 |
| Cash and equivalnt end of year | 0.57 | 1.35 | 1.19 | -2.22 | -1.87 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis